BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30886189)

  • 1. Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China.
    Liao Z; Qiu M; Yang J; Yang Y; Zhu L; Yang B; Bai X; Xing P; Zhang J; Xing R; Teng S; Zhao J
    Sci Rep; 2019 Mar; 9(1):4816. PubMed ID: 30886189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
    Sio TT; Vu CC; Sohawon S; Van Houtte P; Thariat J; Novotny PJ; Miller RC; Bar-Sela G
    Am J Clin Oncol; 2016 Feb; 39(1):32-6. PubMed ID: 24401667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
    Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
    Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy.
    Paludo J; Fritchie K; Haddox CL; Rose PS; Arndt CAS; Marks RS; Galanis E; Okuno SH; Robinson SI
    Am J Clin Oncol; 2018 Sep; 41(9):832-837. PubMed ID: 28622153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
    Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
    Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.
    Wakamatsu T; Kakunaga S; Takenaka S; Outani H; Hamada K; Imura Y; Hori Y; Naka N; Kudawara I; Yoshikawa H; Ueda T
    Int J Clin Oncol; 2019 Oct; 24(10):1311-1319. PubMed ID: 31197555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of outcomes in extraskeletal osteosarcoma: a review of fifty-three cases.
    Choi LE; Healey JH; Kuk D; Brennan MF
    J Bone Joint Surg Am; 2014 Jan; 96(1):e2. PubMed ID: 24382730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
    Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
    Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
    Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
    Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma.
    Heng M; Gupta A; Chung PW; Healey JH; Vaynrub M; Rose PS; Houdek MT; Lin PP; Bishop AJ; Hornicek FJ; Chen YL; Lozano-Calderon S; Holt GE; Han I; Biau D; Niu X; Bernthal NM; Ferguson PC; Wunder JS; ;
    Eur J Cancer; 2020 Jan; 125():130-141. PubMed ID: 31806415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
    Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
    Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Treatment and Outcomes of Extraskeletal Osteosarcoma: Institutional Experience and Review of The Literature.
    Nystrom LM; Reimer NB; Reith JD; Scarborough MT; Gibbs CP
    Iowa Orthop J; 2016; 36():98-103. PubMed ID: 27528844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of 853 high grade osteosarcomas from a single institution-Are outcomes in Indian patients different?
    Puri A; Byregowda S; Gulia A; Crasto S; Chinaswamy G
    J Surg Oncol; 2018 Feb; 117(2):299-306. PubMed ID: 28833209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
    Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.